From prediction error to psychosis: Ketamine as a pharmacological model of delusions

Journal of Psychopharmacology

Volumn 21, Issue 3, 2007, Pages 238-252

  Corlett, P R ^a   Honey, G D ^a   Fletcher, P C ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; CANNABIS; DOPAMINE; DOPAMINE RECEPTOR BLOCKING AGENT; GLUTAMIC ACID; KETAMINE; PHOSPHOPROTEIN DARPP 32; PSILOCYBINE; PSYCHEDELIC AGENT; RACLOPRIDE;

ACUTE PSYCHOSIS; ATTENTION DISTURBANCE; COGNITION; DELUSION; DISEASE COURSE; DISEASE MODEL; DOPAMINERGIC ACTIVITY; DOPAMINERGIC SYSTEM; HUMAN; LEARNING DISORDER; LEARNING ENVIRONMENT; MENTAL DISEASE; NEUROBIOLOGY; NONHUMAN; PERCEPTIVE DISCRIMINATION; PREDICTION; PRIORITY JOURNAL; PSYCHOSIS; REVIEW; SCHIZOPHRENIA; STATE DEPENDENT LEARNING;

ANIMALS; ASSOCIATION LEARNING; DELUSIONS; DOPAMINE; EXCITATORY AMINO ACID ANTAGONISTS; GLUTAMIC ACID; HALLUCINOGENS; HUMANS; KETAMINE; MENTAL PROCESSES; MODELS, PSYCHOLOGICAL; SYNAPTIC TRANSMISSION;

EID: 34250689063     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881107077716     Document Type: Review

References (211)

1. Aalto S., Ihalainen J., Hirvonen J., Kajander J., Scheinin H., Tanila H., Nagren K., Vilkman H., Gustafsson L.L., Syvalahti E., Hietala J. (2005) Cortical glutamate-dopamine interaction and ketamine-induced psychotic symptoms in man. Psychopharmacology (Berl) 182: 375 - 383
2. Abel K.M., Allin M.P., Hemsley D.R., Geyer M.A. (2003) Low dose ketamine increases prepulse inhibition in healthy men. Neuropharmacology 44: 729 - 737
3. Adler C.M., Goldberg T.E., Malhotra A.K., Pickar D., Breier A. (1998) Effects of ketamine on thought disorder, working memory, and semantic memory in healthy volunteers. Biol Psychiatry 43: 811 - 816
4. Ahn S., Phillips A.G. (1999) Dopaminergic correlates of sensory-specific satiety in the medial prefrontal cortex and nucleus accumbens of the rat. J Neurosci 19: RC29
5. Alves C.R., Silva M.T. (2001) Facilitation of latent inhibition by the atypical antipsychotic risperidone. Pharmacol Biochem Behav 68: 503 - 506
6. Anand A., Charney D.S., Oren D.A., Berman R.M., Hu X.S., Cappiello A., Krystal J.H. (2000) Attenuation of the neuropsychiatric effects of ketamine with lamotrigine: support for hyperglutamatergic effects of N-methyl-D-aspartate receptor antagonists. Arch Gen Psychiatry 57: 270 - 276
7. Anden N.E., Butcher S.G., Corrodi H., Fuxe K., Ungerstedt U. (1970) Receptor activity and turnover of dopamine and noradrenaline after neuroleptics. Eur J Pharmacol 11: 303 - 314
8. Andersson M., Usiello A., Borgkvist A., Pozzi L., Dominguez C., Fienberg A.A., Svenningsson P., Fredholm B.B., Borrelli E., Greengard P., Fisone G. (2005) Cannabinoid action depends on phosphorylation of dopamine-and cAMP-regulated phosphoprotein of 32 kDa at the protein kinase A site in striatal projection neurons. J Neurosci 25: 8432 - 8438
9. Angrist B.M., Gershon S. (1970) The phenomenology of experimentally induced amphetamine psychosis-preliminary observations. Biol Psychiatry 2: 95 - 107
10. Arieti S. (1955) Interpretation of Schizophrenia. NY: Robert Brunner
11. Arieti S. (1974) An overview of schizophrenia from a predominantly psychological approach. Am J Psychiatry 131: 241 - 249
12. Aron A.R., Shohamy D., Clark J., Myers C., Gluck M.A., Poldrack R.A. (2004) Human midbrain sensitivity to cognitive feedback and uncertainty during classification learning. J Neurophysiol 92: 1144 - 1152
13. Bao S., Chan V.T., Merzenich M.M. (2001) Cortical remodelling induced by activity of ventral tegmental dopamine neurons. Nature 412: 79 - 83
14. Bao S., Chan V.T., Zhang L.I., Merzenich M.M. (2003) Suppression of cortical representation through backward conditioning. Proc Natl Acad Sci U S A 100: 1405 - 1408
15. Barch D.M. (2005) What can research on schizophrenia tell us about the cognitive neuroscience of working memory ? Neuroscience
16. Baruch I., Hemsley D.R., Gray J.A. (1988) Differential performance of acute and chronic schizophrenics in a latent inhibition task. J Nerv Ment Dis 176: 598 - 606
17. Bell D.S. (1965) Comparison of amphetamine psychosis and schizophrenia. Br J Psychiatry 111: 701 - 707
18. Bell D.S. (1973) The experimental reproduction of amphetamine psychosis. Arch Gen Psychiatry 29: 35 - 40
19. Bender S., Muller B., Oades R.D., Sartory G. (2001) Conditioned blocking and schizophrenia: a replication and study of the role of symptoms, age, onset-age of psychosis and illness-duration. Schizophr Res 49: 157 - 170
20. Beninger R.J. (1988) The Slow Therapeutic Action of Antipsychotic Drugs: A Possible Mechanism Involving the Role of Dopamine in Incentive Learning. Karger, Basel
21. Berns G.S., McClure S.M., Pagnoni G., Montague P.R. (2001) Predictability modulates human brain response to reward. J Neurosci 21: 2793 - 2798
22. Berridge K.C., Robinson T.E. (1998) What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience? Brain Res Brain Res Rev 28: 309 - 369
23. Berze J. (1914) Die primare Insuffizienz der psychischen Aktivitat. Ihr Wesen, ihre Erschienungen und ihre Bedeutung als Grundstorungen der Dementia Praecox und der hypophrenen Uberhaupt. Leipzig: Franz Deuticke
24. Blakemore S.J., Wolpert D.M., Frith C.D. (2002) Abnormalities in the awareness of action. Trends Cogn Sci 6: 237 - 242
25. Bowdle T.A., Radant A.D., Cowley D.S., Kharasch E.D., Strassman R.J., Roy-Byrne P.P. (1998) Psychedelic effects of ketamine in healthy volunteers: relationship to steady-state plasma concentrations. Anesthesiology 88: 82 - 88
26. Braver T.S., Barch D.M., Cohen J.D. (1999) Cognition and control in schizophrenia: a computational model of dopamine and prefrontal function. Biol Psychiatry 46: 312 - 328
27. Braver T.S., Cohen J.D. (1999) Dopamine, cognitive control, and schizophrenia: the gating model. Prog Brain Res 121: 327 - 349
28. Breier A., Adler C.M., Weisenfeld N., Su T.P., Elman I., Picken L., Malhotra A.K., Pickar D. (1998) Effects of NMDA antagonism on striatal dopamine release in healthy subjects: application of a novel PET approach. Synapse 29: 142 - 147
29. Bremner J.D., Krystal J.H., Putnam F.W., Southwick S.M., Marmar C., Charney D.S., Mazure C.M. (1998) Measurement of dissociative states with the Clinician-Administered Dissociative States Scale (CADSS). J Trauma Stress 11: 125 - 136
30. Broadbent D. (1958) Perception and Communication. London: Pergamon
31. Brown P.L., Jenkins H.M. (1968) Auto-shaping of the pigeon's key-peck. J Exp Anal Behav 11: 1 - 8
32. Cameron N. (1939) Schizophrenic thinking in a problem-solving situation. Journal of Mental Science 85: 1012 - 1035
33. Carlsson A., Lindqvist M. (1963) Effect of chlorpromazine or haloperidol on formation of 3methoxytyramine and normetanephrine in mouse brain. Acta Pharmacol Toxicol (Copenh) 20: 140 - 144
34. Carlsson M., Carlsson A. (1990) Interactions between glutamatergic and monoaminergic systems within the basal ganglia-implications for schizophrenia and Parkinson's disease. Trends Neurosci 13: 272 - 276
35. Chapman J. (1966) The early symptoms of schizophrenia. Br J Psychiatry 112: 225 - 251
36. Chiba A.A., Bucci D.J., Holland P.C., Gallagher M. (1995) Basal forebrain cholinergic lesions disrupt increments but not decrements in conditioned stimulus processing. J Neurosci 15: 7315 - 7322
37. Cohen J.D., Servan-Schreiber D. (1992) Context, cortex, and dopamine: a connectionist approach to behavior and biology in schizophrenia. Psychol Rev 99: 45 - 77
38. Connell P. (1958) Amphetamine Psychosis. London: Chapman & Hall
39. Conrad K. (1958) Die Beginnende Schizophrenie. Stuttgart: G. Thieme
40. Corbett R., Camacho F., Woods A.T., Kerman L.L., Fishkin RJ, Brooks K., Dunn R.W. (1995) Antipsychotic agents antagonize non-competitive N-methyl-D-aspartate antagonist-induced behaviors. Psychopharmacology (Berl) 120: 67 - 74
41. Corlett P.R., Aitken M.R., Dickinson A. Shanks D.R., Honey G.D., Honey R.A., Robbins T.W., Bullmore E.T., Fletcher P.C. (2004) Prediction error during retrospective revaluation of causal associations in humans: fMRI evidence in favor of an associative model of learning. Neuron 44: 877 - 888
42. Corlett P.R., Honey G.D., Aitken M R F, Dickinson A., Shanks D.R., Absalom A.R., Lee M., Pomarol-Clotet E., Murray G.K., McKenna P.J., Robbins T.W., Bullmore E.T., Fletcher P.C. (2006) Frontal responses during learning predict vulnerability to the psychotogenic effects of ketamine: linking cognition, brain activity and psychosis. Arch Gen Psychiatry 63: 611 - 621
43. Creese I., Burt D.R., Snyder S.H. (1976) Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs. Science 192: 481 - 483
44. D'Souza D.C., Perry E., MacDougall L., Ammerman Y., Cooper T., Wu Y.T., Braley G., Gueorguieva R., Krystal J.H. (2004) The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: implications for psychosis. Neuropsychopharmacology 29: 1558 - 1572
45. Dalley J.W., Laane K., Theobald D.E., Armstrong H.C., Corlett P.R., Chudasama Y., Robbins T.W. (2005) Time-limited modulation of appetitive Pavlovian memory by D1 and NMDA receptors in the nucleus accumbens. Proc Natl Acad Sci USA 102: 6189 - 6194
46. Dayan P., Kakade S., Montague P.R. (2000) Learning and selective attention. Nat Neurosci 3 (Suppl). 1218 - 1223
47. Del Arco A., Mora F. (2000) Endogenous dopamine potentiates the effects of glutamate on extracellular GABA in the prefrontal cortex of the freely moving rat. Brain Res Bull 53: 339 - 345
48. Di Ciano P, Cardinal R.N., Cowell R.A., Little S.J., Everitt B.J. (2001) Differential involvement of NMDA, AMPA/kainate, and dopamine receptors in the nucleus accumbens core in the acquisition and performance of pavlovian approach behavior. J Neurosci 21: 9471 - 9477
49. Dickinson A. (2001) The 28th Bartlett Memorial Lecture. Causal learning: an associative analysis. Q J Exp Psychol B 54: 3 - 25
50. Dreher J.C., Kohn P., Berman K.F. (2005) Neural coding of distinct statistical properties of reward information in humans. Cereb Cortex
51. Einhorn H.J., Hogarth R.M. (1986) Judging probable cause. Psychological Bulletin 99: 3 - 19
52. Escobar M., Oberling P., Miller R.R. (2002) Associative deficit accounts of disrupted latent inhibition and blocking in schizophrenia. Neurosci Biobehav Rev 26: 203 - 216
53. Everitt B.J., Robbins T.W. (1997) Central cholinergic systems and cognition. Annu Rev Psychol 48: 649 - 684
54. Feenstra M.G., Botterblom M.H. (1996) Rapid sampling of extracellular dopamine in the rat prefrontal cortex during food consumption, handling and exposure to novelty. Brain Res 742: 17 - 24
55. Feenstra M.G., Botterblom M.H., Mastenbroek S. (2000) Dopamine and noradrenaline efflux in the prefrontal cortex in the light and dark period: effects of novelty and handling and comparison to the nucleus accumbens. Neuroscience 100: 741 - 748
56. Feenstra M.G., van der Weij W., Botterblom M.H. (1995) Concentration-dependent dual action of locally applied N-methyl-D-aspartate on extracellular dopamine in the rat prefrontal cortex in vivo. Neurosci Lett 201: 175 - 178
57. Fibiger H.C., Phillips A.G., Zis A.P. (1974) Deficits in instrumental responding after 6-hydroxydopamine lesions of the nigro-neostriatal dopaminergic projection. Pharmacol Biochem Behav 2: 87 - 96
58. Finlay J.M., Zigmond M.J. (1997) The effects of stress on central dopaminergic neurons: possible clinical implications. Neurochem Res 22: 1387 - 1394
59. Finlay J.M., Zigmond M.J., Abercrombie E.D. (1995) Increased dopamine and norepinephrine release in medial prefrontal cortex induced by acute and chronic stress: effects of diazepam. Neuroscience 64: 619 - 628
60. Fiorillo C.D., Tobler P.N., Schultz W. (2003) Discrete coding of reward probability and uncertainty by dopamine neurons. Science 299: 1898 - 1902
61. Fiorillo C.D., Tobler P.N., Schultz W. (2005) Evidence that the delay-period activity of dopamine neurons corresponds to reward uncertainty rather than backpropagating T D errors. Behav Brain Funct 1: 7
62. Fletcher P.C., Anderson J.M., Shanks D.R., Honey R., Carpenter T.A., Donovan T., Papadakis N., Bullmore E.T. (2001) Responses of human frontal cortex to surprising events are predicted by formal associative learning theory. Nat Neurosci 4: 1043 - 1048
63. Floresco S.B., Blaha C.D., Yang C.R., Phillips A.G. (2001) Dopamine D1 and NMDA receptors mediate potentiation of basolateral amygdala-evoked firing of nucleus accumbens neurons. J Neurosci 21: 6370 - 6376
64. Freedman B., Chapman L.J. (1973) Early subjective experience in schizophrenic episodes. J Abnorm Psychol 82: 46 - 54
65. Freedman B.J. (1974) The subjective experience of perceptual and cognitive disturbances in schizophrenia. A review of autobiographical accounts. Arch Gen Psychiatry 30: 333 - 340
66. Freeman A.S., Bunney B.S. (1984) The effects of phencyclidine and N-allylnormetazocine on midbrain dopamine neuronal activity. Eur J Pharmacol 104: 287 - 293
67. Friston K. (2005) Disconnection and cognitive dysmetria in schizophrenia. Am J Psychiatry 162: 429 - 432
68. Frith C.D., Blakemore S.J., Wolpert D.M. (2000) Abnormalities in the awareness and control of action. Philos Trans R Soc Lond B Biol Sci 355: 1771 - 1788
69. Fuster J.M. (1985) The prefrontal cortex, mediator of cross-temporal contingencies. Human Neurobiology 4: 169 - 179
70. Gal G., Schiller D., Weiner I. (2005) Latent inhibition is disrupted by nucleus accumbens shell lesion but is abnormally persistent following entire nucleus accumbens lesion: The neural site controlling the expression and disruption of the stimulus preexposure effect. Behav Brain Res 162: 246 - 255
71. Goldman-Rakic P.S. (1994) Working memory dysfunction in schizophrenia. J Neuropsychiatry Clin Neurosci 6: 348 - 357
72. Gray J.A. (1993) Consciousness, schizophrenia and scientific theory. Ciba Found Symp 174: 263 - 273 ; discussion 273 - 281
73. Gray J.A. (1995) Dopamine release in the nucleus accumbens: the perspective from aberrations of consciousness in schizophrenia. Neuropsychologia 33: 1143 - 1153
74. Gray J.A. (1998 a) Abnormal contents of consciousness: the transition from automatic to controlled processing. Adv Neurol 77: 195 - 208 ; discussion 208 - 211
75. Gray J.A. (1998 b) Integrating schizophrenia. Schizophr Bull 24: 249 - 266
76. Gray J.A. (2004) On biology, phenomenology, and pharmacology in schizophrenia. Am J Psychiatry 161: 377 ; author reply 377 - 378
77. Gray J.A., Joseph M.H., Hemsley D.R., Young A.M., Warburton E.C., Boulenguez P., Grigoryan G.A., Peters S.L., Rawlins J N P, Taib C-T., Yee B.K., Cassaday H., Weiner I., Gal G., Gusak O., Joel D., Shadach E., Shalev U., Tarrasch R., Feldon J. (1995) The role of mesolimbic dopaminergic and retrohippocampal afferents to the nucleus accumbens in latent inhibition: implications for schizophrenia. Behav Brain Res 71: 19 - 31
78. Gray N.S., Snowden R.J. (2005) The relevance of irrelevance to schizophrenia. Neurosci Biobehav Rev 29: 989 - 999
79. Greengard P. (2001) The neurobiology of slow synaptic transmission. Science 294: 1024 - 1030
80. Greenwald A.G. (1980) The totalitarian ego. American Psychologist 35: 603 - 618
81. Grossberg S. (1982) Processing of expected and unexpected events during conditioning and attention: a psychophysiological theory. Psychol Rev 89: 529 - 572
82. Hasler F., Grimberg U., Benz M.A., Huber T., Vollenweider F.X. (2004) Acute psychological and physiological effects of psilocybin in healthy humans: a double-blind, placebo-controlled dose-effect study. Psychopharmacology (Berl) 172: 145 - 156
83. Hemsley D.R. (1992) Cognitive abnormalities and schizophrenic symptoms. Psychol Med 22: 839 - 842
84. Hemsley D.R. (1993) A simple (or simplistic?) cognitive model for schizophrenia. Behav Res Ther 31: 633 - 645
85. Hemsley D.R. (1994) A cognitive model for schizophrenia and its possible neural basis. Acta Psychiatr Scand Suppl 384: 80 - 86
86. Hemsley D.R. (1996) Schizophrenia. A cognitive model and its implications for psychological intervention. Behav Modif 20: 139 - 169
87. Hemsley D.R. (1998) The disruption of the 'sense of self ' in schizophrenia: potential links with disturbances of information processing. Br J Med Psychol 71 (Pt 2). 115 - 124
88. Hemsley D.R. (2005 a) The development of a cognitive model of schizophrenia: placing it in context. Neurosci Biobehav Rev 29: 977 - 988
89. Hemsley D.R. (2005 b) The schizophrenic experience: taken out of context? Schizophr Bull 31: 43 - 53
90. Heyser C.J., Fienberg A.A., Greengard P., Gold L.H. (2000) DARPP-32 knockout mice exhibit impaired reversal learning in a discriminated operant task. Brain Res 867: 122 - 130
91. Hoffman D.C. (1992) Typical and atypical neuroleptics antagonize MK-801-induced locomotion and stereotypy in rats. J Neural Transm Gen Sect 89: 1 - 10
92. Hollerman J.R., Schultz W. (1998) Dopamine neurons report an error in the temporal prediction of reward during learning. Nat Neurosci 1: 304 - 309
93. Hollerman J.R., Tremblay L., Schultz W. (1998) Influence of reward expectation on behavior-related neuronal activity in primate striatum. J Neurophysiol 80: 947 - 963
94. Honey G.D., O'Loughlin C., Turner D.C., Pomarol-Clotet E., Corlett P.R., Fletcher P.C. (2005) The effects of a subpsychotic dose of ketamine on recognition and source memory for agency: implications for pharmacological modelling of core symptoms of schizophrenia. Neuropsychopharmacology
95. Honey R.A., Turner D.C., Honey G.D., Sharar S.R., Kumaran D., Pomarol-Clotet E., McKenna P., Sahakian B.J., Robbins T.W., Fletcher P.C. (2003) Subdissociative dose ketamine produces a deficit in manipulation but not maintenance of the contents of working memory. Neuropsychopharmacology 28: 2037 - 2044
96. Honey R.A., Honey G.D., O'Loughlin C., Sharar S.R., Kumaran D., Bullmore E.T., Menon D.K., Donovan T., Lupson V.C., Bisbrown-Chippendale R., Fletcher P.C. (2004) Acute ketamine administration alters the brain responses to executive demands in a verbal working memory task: an FMRI study. Neuropsychopharmacology 29: 1203 - 1214
97. Jones S.H., Gray J.A., Hemsley D.R. (1992) Loss of the Kamin blocking effect in acute but not chronic schizophrenics. Biol Psychiatry 32: 739 - 755
98. Kamin L.J. (1969) Predictability, surprise, attention and conditioning. In Church R, Campbell B (eds). Punishment and Aversive Behavior. New York: Appleton-Century-Crofts, 279 - 296
99. Kaney S., Bentall R.P. (1992) Persecutory delusions and the self-serving bias. Evidence from a contingency judgment task. J Nerv Ment Dis 180: 773 - 780
100. Kapur S. (2003) Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia. Am J Psychiatry 160: 13 - 23
101. Kapur S. (2004) How antipsychotics become anti-"psychotic"-from dopamine to salience to psychosis. Trends Pharmacol Sci 25: 402 - 406
102. Kapur S., Mizrahi R., Li M. (2005) From dopamine to salience to psychosis-linking biology, pharmacology and phenomenology of psychosis. Schizophr Res 79: 59 - 68
103. Kapur S., Seeman P. (2001) Ketamine has equal affinity for NMDA receptors and the high-affinity state of the dopamine D2 receptor. Biol Psychiatry 49: 954 - 957
104. Keefe R.S., Arnold M.C., Bayen U.J., Harvey P.D. (1999) Source monitoring deficits in patients with schizophrenia; a multinomial modelling analysis. Psychol Med 29: 903 - 914
105. Kegeles L.S., Abi-Dargham A., Zea-Ponce Y., Rodenhiser-Hill J., Mann J.J., Van Heertum R.L., Cooper T.B., Carlsson A., Laruelle M. (2000) Modulation of amphetamine-induced striatal dopamine release by ketamine in humans: implications for schizophrenia. Biol Psychiatry 48: 627 - 640
106. Kelley A.E., Berridge K.C. (2002) The neuroscience of natural rewards: relevance to addictive drugs. J Neurosci 22: 3306 - 3311
107. Kelley A.E., Smith-Roe S.L., Holahan M.R. (1997) Response-reinforcement learning is dependent on N-methyl-D-aspartate receptor activation in the nucleus accumbens core. Proc Natl Acad Sci USA 94: 12174 - 12179
108. Kilhlstrom J.F., Hoyt I.P. (1988) Hypnosis and the psychology of delusions. New York: Wiley
109. Kreitschmann-Andermahr I., Rosburg T., Demme U., Gaser E., Nowak H., Sauer H. (2001) Effect of ketamine on the neuromagnetic mismatch field in healthy humans. Brain Res Cogn Brain Res 12: 109 - 116
110. Krystal J.H., Karper L.P., Seibyl J.P., Freeman G.K., Delaney R., Bremner J.D., Heninger G.R., Bowers M B, Jr., Charney D.S. (1994) Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch Gen Psychiatry 51: 199 - 214
111. Krystal J.H., Karper L.P., Bennett A., D'Souza D.C., Abi-Dargham A., Morrissey K., Abi-Saab D., Bremner J.D., Bowers M.B., Jr., Suckow R.F., Stetson P., Heninger G.R., Charney D.S. (1998) Interactive effects of subanesthetic ketamine and subhypnotic lorazepam in humans. Psychopharmacology (Berl) 135: 213 - 229
112. Krystal J.H., D'Souza D.C., Karper L.P. Bennett A., Abi-Dargham A., Abi-Saab D., Cassello K., Bowers M B., Jr., Vegso S., Heninger G.R., Charney D.S. (1999) Interactive effects of subanesthetic ketamine and haloperidol in healthy humans. Psychopharmacology (Berl) 145: 193 - 204
113. Krystal J.H., Bennett A., Abi-Saab D., Belger A., Karper LP, D'Souza DC, Lipschitz D., Abi-Dargham A., Charney DS (2000) Dissociation of ketamine effects on rule acquisition and rule implementation: possible relevance to NMDA receptor contributions to executive cognitive functions. Biol Psychiatry 47: 137 - 143
114. Krystal J.H., Abi-Saab W., Perry E., D'Souza DC, Liu N., Gueorguieva R., McDougall L., Hunsberger T., Belger A., Levine L., Breier A. (2005 a) Preliminary evidence of attenuation of the disruptive effects of the NMDA glutamate receptor antagonist, ketamine, on working memory by pretreatment with the group II metabotropic glutamate receptor agonist, LY354740, in healthy human subjects. Psychopharmacology (Berl) 179: 303 - 309
115. Krystal J.H., Perry E.B., Jr, Gueorguieva R., Belger A., Madonick S.H., Abi-Dargham A., Cooper T.B., Macdougall L., Abi-Saab W., D'Souza D.C. (2005 b) Comparative and interactive human psychopharmacologic effects of ketamine and amphetamine: implications for glutamatergic and dopaminergic model psychoses and cognitive function. Arch Gen Psychiatry 62: 985 - 994
116. Lavin A., Nogueira L., Lapish C.C., Wightman R.M., Phillips P.E., Seamans J.K. (2005) Mesocortical dopamine neurons operate in distinct temporal domains using multimodal signaling. J Neurosci 25: 5013 - 5023
117. Ljungberg T., Apicella P., Schultz W. (1992) Responses of monkey dopamine neurons during learning of behavioral reactions. J Neurophysiol 67: 145 - 163
118. Lubow R.E. (1965) Latent inhibition: effects of frequency of nonreinforced preexposure of the CS. J Comp Physiol Psychol 60: 454 - 457
119. Lubow R.E., Gewirtz J.C. (1995) Latent inhibition in humans: data, theory, and implications for schizophrenia. Psychol Bull 117: 87 - 103
120. Lubow R.E., Moore A.U. (1959) Latent inhibition: the effect of nonreinforced pre-exposure to the conditional stimulus. J Comp Physiol Psychol 52: 415 - 419
121. Mackintosh N.J. (1975) A theory of attention: Variations in associability of stimuli with reinforcement. Psychological Review 82: 276 - 298
122. Maher B.A. (1974) Delusional thinking and perceptual disorder. J Individ Psychol 30: 98 - 113
123. Maher B.A. (1988) Delusions as Normal Theories. New York: Wiley
124. Maj J., Rogoz Z., Skuza G. (1991) Locomotor hyperactivity induced by MK-801 in rats. Pol J Pharmacol Pharm 43: 449 - 458
125. Maldonado-Irizarry C.S., Kelley A.E. (1995) Excitatory amino acid receptors within nucleus accumbens subregions differentially mediate spatial learning in the rat. Behav Pharmacol 6: 527 - 539
126. Martins Serra A, Jones S.H., Toone B., Gray J.A. (2001) Impaired associative learning in chronic schizophrenics and their first-degree relatives: a study of latent inhibition and the Kamin blocking effect. Schizophr Res 48: 273 - 289
127. Mathe J.M., Nomikos G.G., Schilstrom B., Svensson T.H. (1998) Non-NMDA excitatory amino acid receptors in the ventral tegmental area mediate systemic dizocilpine (MK-801) induced hyperlocomotion and dopamine release in the nucleus accumbens. J Neurosci Res 51: 583 - 592
128. Matussek P. (1952) Studies in delusional perception. In Cutting J, Shepherd M (eds). The Clinical Roots of the Schizophrenia Concept. Transaltions of Seminal European Contributions on Schizophrenia. Cambridge: Cambridge University Press, 89 - 103
129. McClure S.M., Berns G.S., Montague P.R. (2003 a) Temporal prediction errors in a passive learning task activate human striatum. Neuron 38: 339 - 346
130. McClure S.M., Daw N.D., Montague P.R. (2003 b) A computational substrate for incentive salience. Trends Neurosci 26: 423 - 428
131. McGhie A., Chapman J. (1961) Disorders of attention and perception in early schizophrenia. Br J Med Psychol 34: 103 - 116
132. McKellar P. (1957) Imagination and Thinking. London: Cohen & West
133. Meyer-Lindenberg A., Straub R.E., Lipska B.K., Verchinski B.A., Goldberg T., Callicott J.H., Egan M.F., Huffaker S.S., Mattay V.S., Kolachana B., Kleinman J.E., Weinberg D.R. (2007) Genetic evidence implicating DARPP-32 in human frontostriatal structure, function, and cognition. J Clin Invest 117: 672 - 682
134. Miller E.K., Cohen J.D. (2001) An integrative theory of prefrontal cortex function. Annu Rev Neurosci 24: 167 - 202
135. Miller R. (1976) Schizophrenic psychology, associative learning and the role of forebrain dopamine. Med Hypotheses 2: 203 - 211
136. Miller R. (1989) Hyperactivity of associations in psychosis. Aust N Z J Psychiatry 23: 241 - 248
137. Miller R. (1993) Striatal dopamine in reward and attention: a system for understanding the symptomatology of acute schizophrenia and mania. Int Rev Neurobiol 35: 161 - 278
138. Mineka S., Kihlstrom J.F. (1978) Unpredictable and uncontrollable events: a new perspective on experimental neurosis. J Abnorm Psychol 87: 256 - 271
139. Mitcham J.C., Thomas R.K., Jr (1972) Effects of substantia nigra and caudate nucleus lesions on avoidance learning in rats. J Comp Physiol Psychol 81: 101 - 107
140. Moghaddam B., Adams B., Verma A., Daly D. (1997) Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex. J Neurosci 17: 2921 - 2927
141. Montague P.R., Hyman S.E., Cohen J.D. (2004) Computational roles for dopamine in behavioural control. Nature 431: 760 - 767
142. Moran P.M., Al-Uzri M.M., Watson J., Reveley M.A. (2003) Reduced Kamin blocking in non paranoid schizophrenia: associations with schizotypy. J Psychiatr Res 37: 155 - 163
143. Morgan C.J., Mofeez A., Brandner B., Bromley L., Curran H.V. (2004) Acute effects of ketamine on memory systems and psychotic symptoms in healthy volunteers. Neuropsychopharmacology 29: 208 - 218
144. Murase S., Mathe J.M., Grenhoff J., Svensson T.H. (1993) Effects of dizocilpine (MK-801) on rat midbrain dopamine cell activity: differential actions on firing pattern related to anatomical localization. J Neural Transm Gen Sect 91: 13 - 25
145. Nelson C.L., Burk J.A., Bruno J.P., Sarter M. (2002) Effects of acute and repeated systemic administration of ketamine on prefrontal acetylcholine release and sustained attention performance in rats. Psychopharmacology (Berl) 161: 168 - 179
146. Newcomer J.W., Farber N.B., Jevtovic-Todorovic V., Selke G., Melson A.K., Hershey T., Craft S., Olney J.W. (1999) Ketamine-induced NMDA receptor hypofunction as a model of memory impairment and psychosis. Neuropsychopharmacology 20: 106 - 118
147. Nicoll R.A. (2003) Expression mechanisms underlying LTP: a post-synaptic view. Philos Trans R Soc Lond B Biol Sci 358: 721 - 726
148. Nyback H., Sedvall G. (1970) Further studies on the accumulation and disappearance of catecholamines formed from tyrosine-14C in mouse brain. Effect of some phenothiazine analogues. Eur J Pharmacol 10: 193 - 205
149. O'Doherty J.P., Dayan P., Friston K., Critchley H., Dolan R.J. (2003) Temporal difference models and reward-related learning in the human brain. Neuron 38: 329 - 337
150. O'Reilly R.C., Braver T.S., Cohen J.D. (1999) A biologically-based neural network model of working memory. In Shah P, Miyake A (eds). Models of Working Memory. Cambridge: Cambridge University Press, 375 - 411
151. Oades R.D., Bunk D., Eggers C. (1992) Paranoid schizophrenics may not use irrelevant signals. The use of measures of blocking and of urinary dopamine. Acta Paedopsychiatr 55: 183 - 184
152. Oades R.D., Zimmermann B., Eggers C. (1996) Conditioned blocking in patients with paranoid, non-paranoid psychosis or obsessive compulsive disorder: associations with symptoms, personality and monoamine metabolism. J Psychiatr Res 30: 369 - 390
153. Oranje B., van Berckel B.N., Kemner C., van Ree J.M., Kahn R.S., Verbaten M.N. (2000) The effects of a sub-anaesthetic dose of ketamine on human selective attention. Neuropsychopharmacology 22: 293 - 302
154. Osmond H. (1957) A review of the clinical effects of psychotomimetic agents. Ann N Y Acad Sci 66: 418 - 434
155. Oye I., Paulsen O., Maurset A. (1992) Effects of ketamine on sensory perception: evidence for a role of N-methyl-D-aspartate receptors. J Pharmacol Exp Ther 260: 1209 - 1213
156. Passie T., Karst M., Wiese B., Emrich H.M., Schneider U. (2005) Effects of different subanesthetic doses of (S)-ketamine on neuropsychology, psychopathology, and state of consciousness in man. Neuropsychobiology 51: 226 - 233
157. Pearce J.M., Hall G. (1980) A model for Pavlovian learning: variations in the effectiveness of conditioned but not of unconditioned stimuli. Psychol Rev 87: 532 - 552
158. Reed G.F. (1972) The Psychology of Anomalous Experience: A Cognitive Approach. London: Hutchinson
159. Rescorla R.A., Wagner A.R. (1972) A theory of Pavlovian conditioning: variations in the effectiveness of reinforcement and non-reinforcement. In Black A H, Prokasy W F (eds). Classical Conditioning II: Current Research and Theory. New York: Appleton-Century-Crofts
160. Rodriguez P.F., Aron A.R., Poldrack R.A. (2005) Ventral-striatal/ nucleusaccumbens sensitivity to prediction errors during classification learning. Hum Brain Mapp
161. Romo R., Schultz W. (1990) Dopamine neurons of the monkey midbrain: contingencies of responses to active touch during self-initiated arm movements. J Neurophysiol 63: 592 - 606
162. Rowland L.M. (2005) Subanesthetic ketamine: how it alters physiology and behavior in humans. Aviat Space Environ Med 76: C52 - C58
163. Rowland L.M., Astur R.S., Jung R.E., Bustillo J.R., Lauriello J., Yeo R.A. (2005) Selective cognitive impairments associated with NMDA receptor blockade in humans. Neuropsychopharmacology 30: 633 - 639
164. Sarter M., Bruno J.P. (1999) Abnormal regulation of corticopetal cholinergic neurons and impaired information processing in neuropsychiatric disorders. Trends Neurosci 22: 67 - 74
165. Sarter M., Nelson C.L., Bruno J.P. (2005) Cortical cholinergic transmission and cortical information processing in schizophrenia. Schizophr Bull 31: 117 - 138
166. Schneider C. (1930) Die Psychologie der Schizophrenen. Leipzig: Germany Thieme
167. Schott B.H., Sellner D.B., Lauer C.J. Habib R., Frey J.U., Guderian S., Heinze H.J., Duzel E. (2004) Activation of midbrain structures by associative novelty and the formation of explicit memory in humans. Learn Mem 11: 383 - 387
168. Schott B.H., Seidenbecher C.I., Fenker D.B., Lauer C.J., Bunzeck N., Bernstein H.G., Tischmeyer W., Gundelfinger E.D., Heinze H.J., Duzel E. (2006) The dopaminergic midbrain participates in human episodic memory formation: evidence from genetic imaging. J Neurosci 26: 1407 - 1417
169. Schultz W., Apicella P., Ljungberg T. (1993 a) Responses of monkey dopamine neurons to reward and conditioned stimuli during successive steps of learning a delayed response task. J Neurosci 13: 900 - 913
170. Schultz W., Apicella P., Ljungberg T., Romo R., Scarnati E. (1993 b) Reward-related activity in the monkey striatum and substantia nigra. Prog Brain Res 99: 227 - 235
171. Schultz W., Dayan P., Montague P.R. (1997) A neural substrate of prediction and reward. Science 275: 1593 - 1599
172. Schultz W., Tremblay L., Hollerman J.R. (1998) Reward prediction in primate basal ganglia and frontal cortex. Neuropharmacology 37: 421 - 429
173. Schultz W. (1998 a) The phasic reward signal of primate dopamine neurons. Adv Pharmacol 42: 686 - 690
174. Schultz W. (1998 b) Predictive reward signal of dopamine neurons. J Neurophysiol 80: 1 - 27
175. Schultz W. (1999) The reward signal of midbrain dopamine neurons. News Physiol Sci 14: 249 - 255
176. Schultz W., Dickinson A. (2000) Neuronal coding of prediction errors. Annu Rev Neurosci 23: 473 - 500
177. Schultz W., Tremblay L., Hollerman J.R. (2000) Reward processing in primate orbitofrontal cortex and basal ganglia. Cereb Cortex 10: 272 - 284
178. Schultz W. (2001) Reward signaling by dopamine neurons. Neuroscientist 7: 293 - 302
179. Schultz W. (2002) Getting formal with dopamine and reward. Neuron 36: 241 - 263
180. Scott L., Kruse M.S., Forssberg H., Brismar H., Greengard P., Aperia A. (2002) Selective up-regulation of dopamine D1 receptors in dendritic spines by NMDA receptor activation. Proc Natl Acad Sci USA 99: 1661 - 1664
181. Seeman P., Chau-Wong M., Tedesco J., Wong K. (1976) Dopamine receptors in human and calf brains, using [3H]apomorphine and an antipsychotic drug. Proc Natl Acad Sci USA 73: 4354 - 4358
182. Sitges M., Nekrassov V., Guarneros A. (2000) Simultaneous action of MK-801 (dizclopine) on dopamine, glutamate, aspartate and GABA release from striatum isolated nerve endings. Brain Res 854: 48 - 56
183. Smith-Roe S.L., Kelley A.E. (2000) Coincident activation of NMDA and dopamine D1 receptors within the nucleus accumbens core is required for appetitive instrumental learning. J Neurosci 20: 7737 - 7742
184. Smith G.S., Schloesser R., Brodie J.D., Dewey SL, Logan J., Vitkun SA, Simkowitz P., Hurley A., Cooper T., Volkow ND, Cancro R. (1998) Glutamate modulation of dopamine measured in vivo with positron emission tomography (PET) and 11C-raclopride in normal human subjects. Neuropsychopharmacology 18: 18 - 25
185. Stephan K.E., Baldeweg T., Friston K.J. (2006) Synaptic plasticity and dysconnection in schizophrenia. Biol Psychiatry
186. Svenningsson P., Tzavara E.T., Carruthers R., Rachleff I., Wattler S., Nehls M., McKinzie D.L., Fienberg A.A., Nomikos G.G., Greengard P. (2003) Diverse psychotomimetics act through a common signaling pathway. Science 302: 1412 - 1415
187. Svensson T.H., Mathe J.M., Nomikos G.G., Schilstrom B. (1998) Role of excitatory amino acids in the ventral tegmental area for central actions of non-competitive NMDA-receptor antagonists and nicotine. Amino Acids 14: 51 - 56
188. Taber M.T., Fibiger H.C. (1997) Activation of the mesocortical dopamine system by feeding: lack of a selective response to stress. Neuroscience 77: 295 - 298
189. Taylor S.E., Fiske S.T. (1978) Salience, Attention and Attribution: Top of the Head Phenomena, Vol 11. San Diego: CA: Academic Press
190. Tobler P.N., O'Doherty J.P., Dolan R.J., Schultz W. (2005) Human neural learning depends on reward prediction errors in the blocking paradigm. J Neurophysiol
191. Turner D.C., Aitken M.R., Shanks D.R., Sahakian B.J., Robbins T.W., Schwarzbauer C., Fletcher P.C. (2004) The role of the lateral frontal cortex in causal associative learning: exploring preventative and super-learning. Cereb Cortex 14: 872 - 880
192. Umbricht D., Koller R., Vollenweider F.X., Schmid L. (2002) Mismatch negativity predicts psychotic experiences induced by NMDA receptor antagonist in healthy volunteers. Biol Psychiatry 51: 400 - 406
193. Umbricht D., Schmid L., Koller R., Vollenweider F.X., Hell D., Javitt D.C. (2000) Ketamine-induced deficits in auditory and visual context-dependent processing in healthy volunteers: implications for models of cognitive deficits in schizophrenia. Arch Gen Psychiatry 57: 1139 - 1147
194. Vaitl D., Lipp O., Bauer U. Schuler G., Stark R., Zimmermann M., Kirsch P. (2002) Latent inhibition and schizophrenia: Pavlovian conditioning of autonomic responses. Schizophr Res 55: 147 - 158
195. Vollenweider F.X., Leenders K.L., Oye I., Hell D., Angst J. (1997 a) Differential psychopathology and patterns of cerebral glucose utilisation produced by (S). and (R)-ketamine in healthy volunteers using positron emission tomography (PET). Eur Neuropsychopharmacol 7: 25 - 38
196. Vollenweider F.X., Leenders K.L., Scharfetter C., Antonini A., Maguire P., Missimer J., Angst J. (1997 b) Metabolic hyperfrontality and psychopathology in the ketamine model of psychosis using positron emission tomography (PET) and [18F] fluorodeoxyglucose (FDG). Eur Neuropsychopharmacol 7: 9 - 24
197. Vollenweider F.X., Vollenweider-Scherpenhuyzen M.F., Babler A., Vogel H., Hell D. (1998) Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action. Neuroreport 9: 3897 - 3902
198. Vollenweider F.X., Vontobel P., Oye I., Hell D., Leenders K.L. (2000) Effects of (S)-ketamine on striatal dopamine: a [11C]raclopride PET study of a model psychosis in humans. J Psychiatr Res 34: 35 - 43
199. Waelti P., Dickinson A., Schultz W. (2001) Dopamine responses comply with basic assumptions of formal learning theory. Nature 412: 43 - 48
200. Watanabe M., Kodama T., Hikosaka K. (1997) Increase of extracellular dopamine in primate prefrontal cortex during a working memory task. J Neurophysiol 78: 2795 - 2798
201. Wedzony K., Golembiowska K., Zazula M. (1994) Differential effects of CGP 37849 and MK-801, competitive and noncompetitive NMDA antagonists, with respect to the modulation of sensorimotor gating and dopamine outflow in the prefrontal cortex of rats. Naunyn Schmiedebergs Arch Pharmacol 350: 555 - 562
202. Weinberger D.R., Gallhofer B. (1997) Cognitive function in schizophrenia. Int Clin Psychopharmacol 12 (Suppl 4). S29 - S36
203. Whitton P.S., Biggs C.S., Pearce B.R., Fowler L.J. (1992) Regional effects of MK-801 on dopamine and its metabolites studied by in vivo microdialysis. Neurosci Lett 142: 5 - 8
204. Willins D.L., Narayanan S., Wallace L.J., Uretsky N.J. (1993) The role of dopamine and AMPA/kainate receptors in the nucleus accumbens in the hypermotility response to MK801. Pharmacol Biochem Behav 46: 881 - 887
205. Wing J.K., Cooper, J.E., Sartorius N. (1974) The Measurement and Classification of Psychiatric Symptoms. Cambridge: Cambridge University Press
206. Yogev H., Sirota P., Gutman Y., Hadar U. (2004) Latent inhibition and overswitching in schizophrenia. Schizophr Bull 30: 713 - 726
207. Young A.M., Kumari V., Mehrotra R., Hemsley DR, Andrew C., Sharma T., Williams SC, Gray JA (2005) Disruption of learned irrelevance in acute schizophrenia in a novel continuous within-subject paradigm suitable for fMRI. Behav Brain Res 156: 277 - 288
208. Young D., Scoville W.B. (1938) Paranoid psychosis in narcolepsy and the possible danger of benzedrine treatment. The Medical Clinics of North America 22: 637 - 646
209. Yu A.J., Dayan P. (2002) Acetylcholine in cortical inference. Neural Netw 15: 719 - 730
210. Yu A.J., Dayan P. (2005) Uncertainty, neuromodulation, and attention. Neuron 46: 681 - 692
211. Zhang J., Chiodo L.A., Freeman A.S. (1992) Electrophysiological effects of MK-801 on rat nigrostriatal and mesoaccumbal dopaminergic neurons. Brain Res 590: 153 - 163